Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Follow-up programme for patients using Symbicort Turbuhaler as maintenance and reliever therapy
2006-005677-22Phase 4Completed
- Sponsor
- AstraZeneca
- Start
- Apr 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of budesonide in asthma, sponsored by AstraZeneca. Primary endpoint: Total daily use of Symbicort. Started Apr 2008; status: completed.
02
Drugs
budesonide
03
Conditions
asthma
Beyond the preview
Go deeper on 2006-005677-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005677-22.